Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
HK Stock MarketDetailed Quotes
MEDICSKIN (08307)
- 0.143
- 0.0000.00%
Not Open Apr 24 09:01 CST
56.73MMarket Cap-47.67P/E (TTM)
0.000High0.000Low0Volume0.143Open0.143Prev Close0.00Turnover0.00%Turnover RatioLossP/E (Static)396.74MShares0.24052wk High13.00P/B56.73MFloat Cap0.02552wk Low--Dividend TTM396.74MShs Float3.824Historical High--Dividend LFY0.00%Range %0.018Historical Low--Avg Price4000Lot Size--Div Yield TTM--Div Yield LFY
MEDICSKIN (08307) Cash Flow
All
YOY
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -10.85%-3.46M | ---- | 15.64%-3.12M | ---- | -183.76%-3.7M | ---- | 236.45%4.42M | ---- | 124.73%1.31M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -53.19%-1.01M | ---- | -32.39%-658K | ---- | -11.43%-497K | ---- | 26.64%-446K | ---- | 30.03%-608K |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -19.35%396K | ---- | -41.55%491K |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | -216.67%-19K | ---- | ---6K | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.94%289K |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.94%289K |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | 53.28%-57K | ---- | -215.09%-122K | ---- | --106K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | 53.28%-57K | ---- | -215.09%-122K | ---- | --106K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.66%-3K | ---- | -5,294.12%-883K |
| -Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3K | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4,141.18%-687K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---196K |
| Depreciation and amortization: | ---- | -3.48%9.06M | ---- | 0.71%9.39M | ---- | -4.17%9.33M | ---- | -0.85%9.73M | ---- | -6.10%9.81M |
| Financial expense | ---- | 35.36%689K | ---- | -34.66%509K | ---- | --779K | ---- | ---- | ---- | ---- |
| Unrealized exchange loss (gain) | ---- | ---- | ---- | -32.16%384K | ---- | 203.66%566K | ---- | -17.42%-546K | ---- | -205.44%-465K |
| Special items | ---- | -329.17%-330K | ---- | -79.10%144K | ---- | 9,742.86%689K | ---- | -85.42%7K | ---- | -76.92%48K |
| Operating profit before the change of operating capital | ---- | -25.49%4.95M | ---- | -6.17%6.65M | ---- | -47.27%7.08M | ---- | 32.91%13.43M | ---- | 44.85%10.11M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 29.60%683K | ---- | 124.40%527K | ---- | -1,610.49%-2.16M | ---- | 170.44%143K | ---- | -2,437.50%-203K |
| Accounts receivable (increase)decrease | ---- | 129.41%25K | ---- | 74.47%-85K | ---- | -766.00%-333K | ---- | 163.16%50K | ---- | -94.19%19K |
| Accounts payable increase (decrease) | ---- | -166.67%-518K | ---- | 243.81%777K | ---- | 118.43%226K | ---- | -158.49%-1.23M | ---- | 399.43%2.1M |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -37.41%343K |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | --1.37M | ---- | ---- | ---- | 61.51%-388K | ---- | ---1.01M |
| Special items for working capital changes | ---- | 142.68%4.36M | ---- | 472.82%1.8M | ---- | 93.78%-482K | ---- | -230.99%-7.76M | ---- | -133.49%-2.34M |
| Cash from business operations | -193.22%-1.02M | -13.88%9.5M | -61.43%1.09M | 154.61%11.04M | 228.42%2.83M | 1.83%4.33M | -53.66%862K | -52.76%4.26M | -66.69%1.86M | -36.28%9.01M |
| Other taxs | ---- | 510.00%41K | --41K | 96.76%-10K | ---- | -1,065.63%-309K | ---- | -76.64%32K | ---- | -82.18%137K |
| Interest paid - operating | -134.44%-354K | 19.06%-412K | ---151K | 34.66%-509K | ---- | -96.72%-779K | ---- | ---396K | ---- | ---- |
| Net cash from operations | -239.71%-1.37M | -13.16%9.13M | -65.31%982K | 223.97%10.52M | 228.42%2.83M | -16.60%3.25M | -53.66%862K | -57.45%3.89M | -66.69%1.86M | -38.65%9.15M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 57.14%374K | 90.14%694K | 150.53%238K | -0.82%365K | 15.85%95K | 21.05%368K | -35.94%82K | -34.76%304K | -69.95%128K | -36.51%466K |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | 216.67%19K | ---- | --6K | ---- | ---- |
| Decrease in deposits (increase) | 733.00%1.27M | 89.04%-40K | -58.73%-200K | 90.30%-365K | -40.00%-126K | -2,266.04%-3.76M | -60.71%-90K | 29.96%-159K | 62.42%-56K | -37.58%-227K |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200K |
| Purchase of fixed assets | -571.53%-920K | 39.51%-845K | 77.94%-137K | 39.26%-1.4M | 17.20%-621K | -17.05%-2.3M | 53.68%-750K | 14.79%-1.97M | -7.43%-1.62M | -35.41%-2.31M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.47%213K |
| Cash on investment | ---1.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -347.47%-443K | 86.33%-191K | 84.82%-99K | 75.38%-1.4M | 13.98%-652K | -212.84%-5.68M | 51.00%-758K | -9.67%-1.81M | 15.33%-1.55M | -104.24%-1.65M |
| Net cash before financing | -305.55%-1.82M | -1.95%8.94M | -59.48%883K | 475.42%9.12M | 1,995.19%2.18M | -216.89%-2.43M | -66.77%104K | -72.27%2.08M | -91.67%313K | -86.11%7.49M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | --9M | --9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Refund | ---73K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 10.60%-135K | ---277K | ---151K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.92M | ---9.92M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.04M |
| Net cash from financing operations | -159.17%-3.04M | 120.50%1.48M | 233.35%5.13M | -6.99%-7.21M | 0.03%-3.85M | 61.60%-6.74M | 72.38%-3.85M | 16.56%-17.55M | 6.26%-13.95M | 22.75%-21.03M |
| Effect of rate | 116.67%1K | -111.11%-2K | -127.27%-6K | 80.00%18K | 103.33%22K | -95.10%10K | -1,322.22%-660K | 257.89%204K | 63.64%54K | 187.69%57K |
| Net Cash | -180.65%-4.85M | 445.78%10.42M | 460.08%6.02M | 120.82%1.91M | 55.40%-1.67M | 40.74%-9.17M | 72.51%-3.75M | -14.27%-15.47M | -22.59%-13.63M | -150.70%-13.54M |
| Begining period cash | 150.38%17.34M | 38.54%6.93M | 38.54%6.93M | -64.68%5M | -64.68%5M | -51.88%14.16M | -51.88%14.16M | -31.42%29.42M | -31.42%29.42M | 169.50%42.91M |
| Cash at the end | -3.45%12.49M | 150.38%17.34M | 286.09%12.94M | 38.54%6.93M | -65.63%3.35M | -64.68%5M | -38.46%9.75M | -51.88%14.16M | -50.20%15.85M | -31.42%29.42M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"